TNNT2 and left ventricular hypertrophy: In addition, elevated hs-cTnT concentrations (≥14 ng/L) in healthy patients without obvious signs of CVD were associated with the risk of developing left ventricular hypertrophy during the 6-year follow-up period (OR = 5.19, 95% CI: 1.49–18.08) [45].